Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net loss	$ (2,545,643)	$ (454,244)	$ (4,059,121)	$ (778,432)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation			2,589,750	184,735
Amortization of debt discount			168,804	179,106
Warrant exercise expense	0	0	211,411	0
Gain on change in fair value of derivative liability			(855,587)	(462,249)
Derivative liability expense	1,059,282	0	1,059,282	61,396
Loss on extinguishment of debt	(28,863)	169,060	180,001	267,881
Changes in operating assets and liabilities:
Accounts payable			86,222	121,907
Accrued interest			53,629	67,475
Accrued compensation			(37,500)	252,000
Net cash used in operating activities			(603,109)	(106,181)
Cash flows from financing activities:
Proceeds from issuance of convertible notes payable			800,000	48,000
Repayment of convertible notes payable			(73,700)	0
Proceeds from notes payable			225,000	0
Advances from (repayments to) officers			(102,340)	39,840
Net cash provided by financing activities			848,960	87,840
Net increase (decrease) in cash			245,849	(18,341)
Cash, beginning of period			30,251	18,668
Cash, end of period	$ 276,102	$ 326	276,102	326
Supplemental disclosures of cash flow information:
Cash paid for interest			40,970	0
Cash paid for income taxes			0	0
Non-cash investing and financing activities:
Issuance of common stock for conversion of notes payable and accrued interest			$ 93,256	$ 223,679